Cardiology

Beta blockers could benefit patients with HFPEF

A novel registry study from Karolinska Institutet in Sweden suggests that beta blockers may benefit also patients suffering from a relatively unknown form of heart failure called HFPEF, which today lacks well-established ...

Cardiology

Beta-blocker therapy cuts all-cause mortality in STEMI

(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), beta-blocker therapy at discharge correlates with reduced all-cause mortality, ...

Cardiology

Sugar overload can damage heart, research shows

Too much sugar can set people down a pathway to heart failure, according to a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth).

Medical research

Study identifies potential new pathway for drug development

A newly found understanding of receptor signaling may have revealed a better way to design drugs. A study from Nationwide Children's Hospital suggests that a newly identified group of proteins, alpha arrestins, may play a ...

Cardiology

Expert: Time to break the beta blocker habit?

First developed in the 1950s, beta blockers have been a mainstay in medicine for decades, used to treat everything from heart disease to stage fright to glaucoma. But some older classes of beta blockers are causing new concerns.

page 10 from 16